Home > Boards > iHub Talk > Other > FDA Approval Treasure Hunters
Followed By 258
Posts 9380
Boards Moderated 0
Alias Born 05/30/2009

Sunday, October 18, 2009 1:54:14 PM

Re: None

Post# of 27
Welcome to FDA Approval Treasure Hunters!!!

Last approval located Friday and the source where located from is IHUB Hunt for next 5-10 bagger:


EPIX: Here is FDA Approval from Friday:


EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
Friday 10/16/2009 3:24 PM ET - Pr Newswire Europe

Related Companies
Symbol Last %Chg
EPIX 0.115 1,050.00%
As of 4:00 PM ET 10/16/09

The FDA has approved a Physician-Sponsored IND and continuation of the fourth 6-month open label extension of PRX-03140, a novel 5HT4 partial agonist for the potential treatment of Alzheimer's Disease. The patient was enrolled initially in a two week Phase 2a study in August 2007 where she received 100 mg per day of PRX-03140 in combination with her normal daily dose of Aricept(R) (10 mg). Based on the marked progress during the original two week study, the patient's daughter sought continued compassionate use of PRX-03140 for her mother and a protocol was submitted to the FDA and approved. The progress seen in the first 2-week study has continued during the past two years (19 months of dosing) and four FDA approved 6-month open label extensions. The latest open label extension will be administered under a new Physician-Sponsored IND under the supervision of Dr. Lucy Hornstein(1). "When I was approached by the patient's daughter to continue the compassionate use therapy of PRX-03140 for her mother, I was compelled by the progress her mother had experienced and the overall apparent safety of the drug," notes Dr. Hornstein.

On July 20, 2009, EPIX Pharmaceuticals, Inc. (the "Company") entered into an Assignment for the Benefit of Creditors (the "Assignment") in accordance with Massachusetts law. The purpose of the Assignment is to conclude the Company's operations and provide for an orderly liquidation of its assets. The Assignment is a common law business liquidation mechanism under Massachusetts law that is an alternative to a formal bankruptcy proceeding. Under the terms of the Assignment, the Company transferred all of its assets to an assignee for orderly liquidation and distribution of the proceeds to the Company's creditors. The designated assignee for the Company is Joseph F. Finn, Jr. at Finn, Warnke & Gayton, 167 Worcester Street, Suite 201, Wellesley Hills, MA 02481.

The PRX-03140 program will be sold at auction on Wednesday, October 21 at 3 pm EDT. Please contact Joseph F. Finn, Jr. at +1-781-237-8840 if you are interested in participating in the auction.

(1) Lucy Hornstein, M.D. is a private practice physician in Valley Forge, PA. She is the author of a recently released book, "Declarations of a Dinosaur: 10 Laws I've Learned as a Family Doctor" by Kaplan Publishing.

AXTG Partner with Save Planet Earth to digitize and plant 100 million trees with NFTs AXTG Aug 11, 2022 10:15 AM

PURA Announces New Development Expanding Cannabis Market Opportunity PURA Aug 11, 2022 9:34 AM

Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis KTTA Aug 11, 2022 8:35 AM

SinglePoint Acquires Frontline Power Solutions, a Multi-State Licensed Energy Services Company SING Aug 11, 2022 8:30 AM

Pacific Booker Minerals Inc. Announces AGM Results and Project Update PBMLF Aug 11, 2022 7:30 AM

GALILEO ANNOUNCES THE START OF REVENUE GENERATION AND ITS EXPANSION PLAN. MDRM Aug 10, 2022 3:23 PM

ResGreen Powers Up - Introduces Wireless Battery Charging for its Fleet of Mobile Robots RGGI Aug 10, 2022 10:53 AM

Kona Gold Beverage, Inc Signs New Distribution Partners in California, Illinois, and Nevada KGKG Aug 10, 2022 9:00 AM

Investing in Quantum Computing: What Every Investor Needs to Know GOOGL Aug 10, 2022 8:45 AM

New Drugs in Pipeline for Hypertension, the Silent Global Pandemic BMY Aug 10, 2022 8:45 AM

Mill City Ventures III, Ltd. provides 2nd Quarter Fiscal 2022 Guidance Revenue Increased 83% year over year and 83% for 6-month period MCVT Aug 10, 2022 8:44 AM

Branded Legacy, Inc. Cancels Another 60 Million Common Shares BLEG Aug 10, 2022 8:30 AM

Defiance Discovers Blind Silver System At Lucita DEF Aug 9, 2022 10:31 AM

USMJ Announces New York Adult Use Cannabis License PURA Aug 9, 2022 10:21 AM

ALYI Announces Building Electric Vehicle Merger and Acquisition Momentum ALYI Aug 9, 2022 10:14 AM